Press Room


facebook sharing button
linkedin sharing button
twitter sharing button

Public Responsibility in Medicine and Research (PRIM&R) is a nonprofit organization dedicated to advancing ethical standards in the conduct of research with humans and animals. We envision a world in which all stakeholders in the research enterprise share an understanding of and commitment to the centrality of ethics to advancing science and medicine. We are active in the research ethics and oversight space—offering education and resources for research ethics committees and research professionals—as well as in public policy.

Members of the media are welcome to contact us for comment, background, or to request a complimentary media registration for upcoming educational offerings. Please contact PRIM&R's Director of Marketing and Communciations Catherine Batsford.

Explore recent press releases and media coverage below and/or search by year above.

PRIM&R Critical of EPA Transparency Rule

May 15, 2020
PRIM&R submitted comments to the EPA in response to their recent supplemental notice of proposed rulemaking on Strengthening Transparency in Regulatory Science joining other science and health groups in voicing serious concern about the rule.

Read more

PRIM&R Comments on Desirable Characteristics of Data Repositories

March 3, 2020
PRIM&R responded to OSTP's Draft Desirable Characteristics of Repositories for Managing and Sharing Data Resulting From Federally Funded Research welcoming this step toward harmonizing policies and enhancing responsible research and presenting some recommendations to enhance the outlined desirable characteristics of data repositories.

Read more

Animal Rehoming and Euthanasia, Sex Bias in Research, and more at IACUC20

February 20, 2020
PRIM&R's 2020 Institutional Animal Care and Use Committee Conference will take place April 5-7 at the Renaissance Orlando at SeaWorld® in Orlando, FL. Complimentary registration is available for credentialed journalists from health, medical, science, and policy outlets or beats.

Read more

PRIM&R Comments on Draft NIH Policy for Data Management and Sharing

January 16, 2020
PRIM&R responded to the NIH "Draft NIH Policy for Data Management and Sharing and Supplement Draft Guidance" applauding the proactive step to accelerate data sharing efforts and offering a few constructive suggestions centered primarily around privacy, informed consent, and oversight funding issues.

Read more

PRIM&R Responds to FDA’s Draft Guidance on Enhancing the Diversity of Clinical Trial Populations

August 2, 2019
PRIM&R responded to the FDA draft guidance on "Enhancing the Diversity of Clinical Trial Populations-Eligibility Criteria, Enrollment Practices, and Trial Designs," calling for more robust discussion of the ethics of enhancing clinical trial diversity and broad recommendation for sponsors to plan for the full range of risks historically underrepresented groups might face.

Read more

PRIM&R Responds to FDA, "Proposed Regulatory Framework for Modifications to AI/ML-Based Software as a Medical Device”

June 10, 2019
PRIM&R responded to the FDA Discussion Paper: "Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning-Based Software as a Medical Device” asking the FDA to consider the ethical impact of generating training data and optimizing algorithmic models through data that comes from interactions with human beings in real time.

Read more

PRIM&R Responds to New NPRM Delaying Revised "Common Rule"

May 14, 2018
PRIM&R recently responded to the new Notice of Proposed Rulemaking (NPRM) proposing to delay the general compliance date for the revised Federal Policy for the Protection of Human Subjects, or "Common Rule," six more months to January 21, 2019 endorsing the proposal under the assumption that the agencies use the delay to produce guidance.

Read more